Dhaval Patel leads UCB’s research organization with the main goal of bringing scientific innovation to patients and helping them live the life they choose.
Dhaval Patel is a medical doctor and holds a PhD in Microbiology and Immunology. He comes to UCB from Novartis, based in their headquarters in Basel, Switzerland, where for 11 years he led various biomedical research teams in areas of neurology, autoimmunity, transplantation and inflammation. In 2010, he became the Head of Research for the Novartis Institutes for BioMedical Research (NIBR) Europe.
For 12 years prior to crossing into industry, Dhaval made a strong mark in the halls of academia and research, specifically at Duke University Medical Center and the University of North Carolina (UNC) at Chapel Hill in North Carolina in the US. He authored and co-authored over 100 thought-leading publications with more than 10,000 citations, and was a member of several top-tier journal editorial boards.
Dhaval is a member of UCB’s Executive Committee. He is also a Clinical Professor at UNC-Chapel Hill and an Independent Director on the Boards of Anokion and Inflazome.